ChemicalBook > CAS DataBase List > bleomycin A6

bleomycin A6

Product Name
bleomycin A6
CAS No.
37293-17-7
Chemical Name
bleomycin A6
Synonyms
Boanmycin;bleomycin A6;Pingyangmycin A6;Zhengguangmycin A6;N1-[3-[[4-[(3-Aminopropyl)amino]butyl]amino]propyl]bleomycinamide;Bleomycinamide, N1-[3-[[4-[(3-aminopropyl)amino]butyl]amino]propyl]-
CBNumber
CB31315485
Molecular Formula
C60H96N20O21S2
Formula Weight
1497.67
MOL File
37293-17-7.mol
More
Less

bleomycin A6 Property

Density 
1.53±0.1 g/cm3(Predicted)
pka
10.84±0.46(Predicted)
More
Less

Safety

Toxicity
LD50 intramuscular in mouse: 70530ug/kg
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

American Custom Chemicals Corporation
Product number
API0013275
Product name
BLEOMYCIN A6
Purity
95.00%
Packaging
5MG
Price
$505.16
Updated
2021/12/16
More
Less

bleomycin A6 Chemical Properties,Usage,Production

Uses

Boanmycin is an antibiotic with antitumor activity that induces cellular senescence and apoptosis[1][2][3].

in vivo

Boanmycin (BAM) (i.p., 10 or 15 mg/kg, twice a week, 5 weeks) can effectively inhibit the growth of tumors in BALB/c nude mice with HT-29, Hce-8693 or CT-26 cells[1].

Animal Model:BALB/c nude mice with HT-29 or Hce-8693 cells[1]
Dosage:10 or 15 mg/kg
Administration:Intraperitoneal injection; twice a week; 5 weeks
Result:Significantly inhibited tumor growth by 89% at 10 mg/kg and by 92% at 15 mg/kg in mice with HT-29 model, also inhibited tumor growth by 90% at 10 mg/kg and by 92% at 15 mg/kg in mice with Hce-8693 model.
Animal Model:BALB/c nude mice with CT-26 cells[1]
Dosage:10 mg/kg
Administration:Intramuscular injection; every second day; 10 times
Result:Inhibited subcutaneous tumor growth by 88% and cecal tumor by 99%.

References

[1] Y C Deng, et al. Activity of boanmycin against colorectal cancer. World J Gastroenterol. 2001 Feb;7(1):93-7. DOI:10.3748/wjg.v7.i1.93
[2] Hao Tang, et al. Effect of boanmycin on apoptosis and cell cycle of human esophageal cancer(Eca-109) cells]. Ai Zheng. 2002 Aug;21(8):855-9. PMID:12478892
[3] Peng Chen, et al. The chemotherapeutic drug boanmycin induces cell senescence and senescence-associated secretory phenotype factors, thus acquiring the potential to remodel the tumor microenvironment. Anticancer Drugs. 2016 Feb;27(2):84-8. DOI:10.1097/CAD.0000000000000304

bleomycin A6 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

bleomycin A6 Suppliers

Shanghai Boyle Chemical Co., Ltd.
Tel
021-50182298 021-50180596
Fax
+86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2208
Advantage
55
ChemStrong Scientific Co.,Ltd
Tel
0755-0755-66853366 13670046396
Fax
0755-28363542
Email
sales@chem-strong.com
Country
China
ProdList
18333
Advantage
56
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19552
Advantage
58
Nantong Hanfang Biotechnology Co. , Ltd.
Tel
hanfangpharma@126.com; 18616537568
Email
hanfangpharma@126.com
Country
China
ProdList
29965
Advantage
58
Changzhou Xianglong Pharmaceutical Technology Co., Ltd.,
Tel
18915873328 18915873328
Email
296197970@qq.com
Country
China
ProdList
11051
Advantage
58

37293-17-7, bleomycin A6Related Search:


  • bleomycin A6
  • N1-[3-[[4-[(3-Aminopropyl)amino]butyl]amino]propyl]bleomycinamide
  • Pingyangmycin A6
  • Zhengguangmycin A6
  • Bleomycinamide, N1-[3-[[4-[(3-aminopropyl)amino]butyl]amino]propyl]-
  • Boanmycin
  • 37293-17-7